Work

Update: Phase I clinical trial to assess safety, tolerability and feasibility of pNGVL4aCRTE6E7L2 HPV DNA vaccine administration via intramuscular TriGrid™ electroporation delivery system in patients with HPV16-positive high-grade cervical, vulvar or vaginal intraepithelial neoplasia